Correction: The MEK1/2 Inhibitor Pimasertib Enhances Gemcitabine Efficacy-Response
Clin Cancer Res
.
2016 Nov 15;22(22):5619.
doi: 10.1158/1078-0432.CCR-16-1542.
PMID:
28151716
DOI:
10.1158/1078-0432.CCR-16-1542
No abstract available
Publication types
Published Erratum